• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阶梯式阿片类药物镇痛方案对剖宫产术后住院期间羟考酮使用和出院处方的影响。

Effect of a stepwise opioid-sparing analgesic protocol on in-hospital oxycodone use and discharge prescription after cesarean delivery.

机构信息

Anesthesiology, Columbia University Vagelos College of Physicians and Surgeons, New York, New York, USA.

Anesthesiology, Montefiore Medical Center, Bronx, New York, USA.

出版信息

Reg Anesth Pain Med. 2021 Feb;46(2):151-156. doi: 10.1136/rapm-2020-102007. Epub 2020 Nov 10.

DOI:10.1136/rapm-2020-102007
PMID:33172902
Abstract

INTRODUCTION

Opioid exposure during hospitalization for cesarean delivery increases the risk of new persistent opioid use. We studied the effectiveness of stepwise multimodal opioid-sparing analgesia in reducing oxycodone use during cesarean delivery hospitalization and prescriptions at discharge.

METHODS

This retrospective cohort study analyzed electronic health records of consecutive cesarean delivery cases in four academic hospitals in a large metropolitan area, before and after implementation of a stepwise multimodal opioid-sparing analgesic computerized order set coupled with provider education. The primary outcome was the proportion of women not using any oxycodone during in-hospital stay ('non-oxycodone user'). In-hospital secondary outcomes were: (1) total in-hospital oxycodone dose among users, and (2) time to first oxycodone pill. Discharge secondary outcomes were: (1) proportion of oxycodone-free discharge prescription, and (2) number of oxycodone pills prescribed.

RESULTS

The intervention was associated with a significant increase in the proportion of non-oxycodone users from 15% to 32% (17% difference; 95% CI 10 to 25), a decrease in total in-hospital oxycodone dose among users, and no change in the time to first oxycodone dose. The adjusted OR for being a non-oxycodone user associated with the intervention was 2.67 (95% CI 2.12 to 3.50). With the intervention, the proportion of oxycodone-free discharge prescription increased from 4.4% to 8.5% (4.1% difference; 95% CI 2.5 to 5.6) and the number of prescribed oxycodone pills decreased from 30 to 18 (-12 pills difference; 95% CI -11 to -13).

CONCLUSIONS

Multimodal stepwise analgesia after cesarean delivery increases the proportion of oxycodone-free women during in-hospital stay and at discharge.

摘要

简介

剖宫产住院期间使用阿片类药物会增加新的持续性阿片类药物使用的风险。我们研究了逐步多模式阿片类药物节约镇痛在减少剖宫产住院期间羟考酮使用和出院时处方的有效性。

方法

这项回顾性队列研究分析了在一个大城市的四个学术医院中连续进行的剖宫产病例的电子健康记录,在实施逐步多模式阿片类药物节约镇痛计算机医嘱单与提供者教育之前和之后。主要结果是住院期间不使用任何羟考酮的女性比例(“非羟考酮使用者”)。住院期间的次要结果是:(1)使用者的总住院羟考酮剂量,和(2)首次羟考酮片的时间。出院时的次要结果是:(1)无羟考酮出院处方的比例,和(2)羟考酮片的数量。

结果

干预措施与非羟考酮使用者的比例从 15%增加到 32%(17%的差异;95%CI 10 至 25)显著相关,使用者的总住院羟考酮剂量减少,首次羟考酮剂量时间无变化。与干预措施相关的非羟考酮使用者的调整比值比为 2.67(95%CI 2.12 至 3.50)。干预后,无羟考酮出院处方的比例从 4.4%增加到 8.5%(4.1%的差异;95%CI 2.5 至 5.6),处方的羟考酮片数量从 30 片减少到 18 片(-12 片差异;95%CI -11 至 -13)。

结论

剖宫产术后多模式逐步镇痛可增加住院期间和出院时无羟考酮女性的比例。

相似文献

1
Effect of a stepwise opioid-sparing analgesic protocol on in-hospital oxycodone use and discharge prescription after cesarean delivery.阶梯式阿片类药物镇痛方案对剖宫产术后住院期间羟考酮使用和出院处方的影响。
Reg Anesth Pain Med. 2021 Feb;46(2):151-156. doi: 10.1136/rapm-2020-102007. Epub 2020 Nov 10.
2
A personalized protocol for prescribing opioids after cesarean delivery: leveraging the electronic medical record to reduce outpatient opioid prescriptions.剖宫产术后开具阿片类药物的个性化方案:利用电子病历减少门诊阿片类药物处方。
Am J Obstet Gynecol. 2024 Apr;230(4):446.e1-446.e6. doi: 10.1016/j.ajog.2023.09.092. Epub 2023 Sep 29.
3
Postdischarge Opioid Prescription after Cesarean: A Quality Improvement Initiative.剖宫产术后出院阿片类药物处方:一项质量改进计划。
Am J Perinatol. 2024 May;41(S 01):e3025-e3029. doi: 10.1055/a-2185-2741. Epub 2023 Oct 3.
4
Opioid prescribing patterns among postpartum women.产后妇女阿片类药物处方模式。
Am J Obstet Gynecol. 2018 Jul;219(1):103.e1-103.e8. doi: 10.1016/j.ajog.2018.04.003. Epub 2018 Apr 7.
5
Implementation of a Quality Improvement Initiative to Decrease Opioid Prescribing After Cesarean Delivery.实施一项质量改进计划,以减少剖宫产术后阿片类药物的处方。
Obstet Gynecol. 2018 Sep;132(3):631-636. doi: 10.1097/AOG.0000000000002789.
6
Scheduled versus as-needed postpartum analgesia and oxycodone utilization.计划性与按需性产后镇痛及羟考酮利用。
J Matern Fetal Neonatal Med. 2022 Mar;35(6):1054-1062. doi: 10.1080/14767058.2020.1742318. Epub 2020 Mar 20.
7
Impact of Enhanced Recovery After Surgery and Opioid-Free Anesthesia on Opioid Prescriptions at Discharge From the Hospital: A Historical-Prospective Study.术后加速康复和非阿片类麻醉对出院时阿片类药物处方的影响:一项历史前瞻性研究。
Anesth Analg. 2017 Nov;125(5):1784-1792. doi: 10.1213/ANE.0000000000002510.
8
Opioid Use and Storage Patterns by Patients after Hospital Discharge following Surgery.手术后出院患者的阿片类药物使用与储存模式
PLoS One. 2016 Jan 29;11(1):e0147972. doi: 10.1371/journal.pone.0147972. eCollection 2016.
9
Effects of State Law Limiting Postoperative Opioid Prescription in Patients After Cesarean Delivery.州法律限制剖宫产术后患者术后阿片类药物处方的效果。
Anesth Analg. 2021 Mar 1;132(3):752-760. doi: 10.1213/ANE.0000000000004993.
10
Hospital opioid use predicts the need for discharge opioid prescriptions following laparoscopic bariatric surgery.医院阿片类药物的使用情况预测了腹腔镜减肥手术后出院阿片类药物处方的需求。
Surg Endosc. 2022 Aug;36(8):6312-6318. doi: 10.1007/s00464-022-09035-x. Epub 2022 Jan 13.

引用本文的文献

1
A time-series analysis of the use of opioid medications in a network of Brazilian hospitals, 2009-2020.2009 - 2020年巴西医院网络中阿片类药物使用情况的时间序列分析。
Lancet Reg Health Am. 2025 Jul 7;48:101167. doi: 10.1016/j.lana.2025.101167. eCollection 2025 Aug.
2
Nudging strategies to influence prescribers' behavior toward reducing opioid prescriptions: a systematic scoping review.推动策略影响开处方者减少阿片类药物处方行为:系统范围界定审查。
J Int Med Res. 2024 Sep;52(9):3000605241272733. doi: 10.1177/03000605241272733.
3
Nonsteroidal anti-inflammatory drug "allergy" labeling is associated with increased postpartum opioid utilization.
非甾体抗炎药的“过敏”标签与产后阿片类药物使用增加有关。
J Allergy Clin Immunol. 2024 Mar;153(3):772-779.e4. doi: 10.1016/j.jaci.2023.11.025. Epub 2023 Nov 30.
4
The future of disparities research in obstetric anesthesia.产科麻醉领域差异研究的未来。
Can J Anaesth. 2023 Jun;70(6):936-941. doi: 10.1007/s12630-023-02447-w. Epub 2023 May 12.
5
Interventions to Reduce Inpatient and Discharge Opioid Prescribing for Postpartum Patients: A Systematic Review.干预措施以减少产后患者的住院和出院阿片类药物处方:系统评价。
J Midwifery Womens Health. 2023 Mar;68(2):187-204. doi: 10.1111/jmwh.13475. Epub 2023 Feb 21.
6
Analgesia in the Initial Management of Acute Pancreatitis: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.急性胰腺炎初始治疗中的镇痛:随机对照试验的系统评价和荟萃分析。
World J Surg. 2022 Apr;46(4):878-890. doi: 10.1007/s00268-021-06420-w. Epub 2022 Jan 7.
7
The risk of serious opioid-related events associated with common opioid prescribing regimens in the postpartum period after cesarean delivery.剖宫产术后产妇常用阿片类药物处方相关的严重阿片类药物相关事件的风险。
Am J Obstet Gynecol MFM. 2021 Nov;3(6):100475. doi: 10.1016/j.ajogmf.2021.100475. Epub 2021 Aug 26.